Milestone Pharmaceuticals (MIST) Operating Expenses (2018 - 2022)

Milestone Pharmaceuticals (MIST) has reported Operating Expenses for 5 consecutive years, with $13.9 million the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Operating Expenses rose 9.19% year-over-year to $13.9 million; the trailing twelve-month figure through Sep 2022 stood at $55.8 million (up 27.45% YoY), and the FY2021 full-year result was $51.1 million, up 14.06% from the prior year.
• Operating Expenses eased to $13.9 million in Q3 2022 per MIST's latest filing, from $14.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $16.4 million in Q4 2019 and bottomed at $3.3 million in Q2 2018.
• Historically, Operating Expenses has averaged $10.7 million across 5 years, with a median of $11.6 million in 2019.
• The sharpest annual moves came in 2019 and 2020: Operating Expenses surged 268.62% in 2019, then tumbled 54.71% in 2020.
• Over 5 years, Operating Expenses stood at $8.5 million in 2018, then jumped by 92.93% to $16.4 million in 2019, then sank by 54.71% to $7.4 million in 2020, then surged by 97.62% to $14.7 million in 2021, then dropped by 5.73% to $13.9 million in 2022.
• According to Business Quant data, Operating Expenses over the past three periods registered $13.9 million, $14.6 million, and $14.7 million for Q3 2022, Q2 2022, and Q4 2021 respectively.